Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 4, 2002, Pages 277-281

  Roller, Regina E ^a   Dorr, A ^a   Ulrich, S ^a   Pilger, E ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aspirin; Peripheral arterial occlusive disease; PFA 100; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; NONSTEROID ANTIINFLAMMATORY AGENT; VON WILLEBRAND FACTOR;

ADULT; AGED; ANALYZER; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BLOOD GROUP ANTIGENS; COLLAGEN; EPINEPHRINE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REFERENCE VALUES; VON WILLEBRAND FACTOR;

EID: 0036592798     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200206000-00001     Document Type: Article

References (15)

1. AIDS now world's fourth biggest killer
2. Collaborative overview of randomized trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. Coagulation, fibrinolytic, and platelet function in patients on long term therapy with aspirin 300 mg or 1200 mg daily compared with placebo
4. Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations
5. Description of an in vitro platelet function analyzer - PFA-100™
6. Preliminary data from a field trial of the PFA-100TM system
7. A comparison of effects of aspirin on bleeding time measured using the Simplate™ method and closure time measured using the PFA-100™ in healthy volunteers
8. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
9. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center
10. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100)
11. Management of peripheral arterial disease (PAD). Transatlantic inter-society consensus (TASC)
12. Von Willebrand disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100™ and a von Willebrand factor/collagen-binding assay
13. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor
14. Influence of ABO blood groups on primary hemostasis
15. Influence of the ABO blood type on the platelet function analyzer PFA-100